Ascariasis

• FDA approval · 2026-04-07
  FDA Approved: IVERMECTIN — Original Application (Ajanta Pharma USA Inc.)

  FDA approved Ajanta Pharma USA Inc.'s original ANDA for ivermectin, making a generic version of the product available for human use. The app…

• FDA approval · 2024-09-04
  FDA Approved: ALBENDAZOLE — Original Application (Alembic Pharmaceuticals Inc.)

  FDA approves Alembic Pharmaceuticals' original application for albendazole, adding a generic version to the market.

• FDA approval · 2021-09-20
  FDA Approved: VERMOX — Supplemental Application (Janssen Pharmaceuticals, Inc.)

  FDA issued a supplemental approval for Vermox (mebendazole) by Janssen Pharmaceuticals, expanding/updates its label.

• FDA approval · 2021-01-26
  FDA Approved: ALBENDAZOLE — Original Application (Dr.Reddys Laboratories Inc)

  FDA has approved Dr. Reddy's Laboratories Inc for albendazole under an Original Application, confirming the generic's authorization for list…

• FDA approval · 2021-01-22
  FDA Approved: ALBENDAZOLE — Original Application (Novadoz Pharmaceuticals LLC)

  FDA approved the original application for albendazole from Novadoz Pharmaceuticals LLC.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2016-10-19
  FDA Approved: VERMOX — Original Application (Janssen Pharmaceuticals, Inc.)

  FDA approved VERMOX (mebendazole) in Janssen's original application; indicated for treatment of common intestinal helminth infections.

• FDA approval · 2009-10-20
  FDA Approved: ALBENDAZOLE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

  FDA approved a supplemental application for Albendazole submitted by Amneal Pharmaceuticals of New York LLC.